Sierra Bancorp (BSRR) Reaches New 52-Week Low at $22.68

Share on StockTwits

Sierra Bancorp (NASDAQ:BSRR) shares reached a new 52-week low during trading on Friday . The company traded as low as $22.68 and last traded at $23.02, with a volume of 39300 shares traded. The stock had previously closed at $24.03.

A number of research analysts have commented on BSRR shares. Hovde Group restated a “buy” rating on shares of Sierra Bancorp in a research note on Monday, January 28th. BidaskClub upgraded Sierra Bancorp from a “sell” rating to a “hold” rating in a research note on Wednesday, January 30th. Zacks Investment Research upgraded Sierra Bancorp from a “sell” rating to a “hold” rating in a research note on Wednesday, March 6th. Finally, ValuEngine cut Sierra Bancorp from a “hold” rating to a “sell” rating in a research note on Wednesday. Three equities research analysts have rated the stock with a sell rating and two have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $31.67.

The firm has a market cap of $372.01 million, a P/E ratio of 12.07, a price-to-earnings-growth ratio of 1.41 and a beta of 0.88. The company has a debt-to-equity ratio of 0.13, a current ratio of 0.82 and a quick ratio of 0.82.

Sierra Bancorp (NASDAQ:BSRR) last posted its earnings results on Tuesday, January 22nd. The financial services provider reported $0.51 EPS for the quarter, missing the consensus estimate of $0.54 by ($0.03). The business had revenue of $29.32 million during the quarter, compared to analysts’ expectations of $29.53 million. Sierra Bancorp had a net margin of 24.09% and a return on equity of 11.29%. As a group, analysts anticipate that Sierra Bancorp will post 2.15 earnings per share for the current fiscal year.

In other Sierra Bancorp news, Director Robb Evans bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, January 31st. The shares were purchased at an average price of $26.79 per share, with a total value of $26,790.00. Following the completion of the acquisition, the director now directly owns 19,000 shares of the company’s stock, valued at approximately $509,010. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Kevin J. Mcphaill sold 15,000 shares of the stock in a transaction on Wednesday, February 20th. The shares were sold at an average price of $27.27, for a total value of $409,050.00. Following the completion of the transaction, the chief executive officer now directly owns 23,076 shares in the company, valued at approximately $629,282.52. The disclosure for this sale can be found here. Insiders purchased 16,500 shares of company stock worth $443,570 in the last three months. 10.21% of the stock is currently owned by corporate insiders.

A number of large investors have recently bought and sold shares of BSRR. Citigroup Inc. grew its holdings in shares of Sierra Bancorp by 18.1% during the fourth quarter. Citigroup Inc. now owns 4,468 shares of the financial services provider’s stock worth $107,000 after purchasing an additional 685 shares during the last quarter. Macquarie Group Ltd. grew its holdings in shares of Sierra Bancorp by 270.3% during the fourth quarter. Macquarie Group Ltd. now owns 1,233 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 900 shares during the last quarter. LSV Asset Management grew its holdings in shares of Sierra Bancorp by 1.1% during the fourth quarter. LSV Asset Management now owns 142,181 shares of the financial services provider’s stock worth $3,416,000 after purchasing an additional 1,581 shares during the last quarter. Penn Capital Management Co. Inc. grew its holdings in shares of Sierra Bancorp by 5.7% during the fourth quarter. Penn Capital Management Co. Inc. now owns 38,103 shares of the financial services provider’s stock worth $916,000 after purchasing an additional 2,044 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Sierra Bancorp by 0.7% during the third quarter. Vanguard Group Inc. now owns 516,435 shares of the financial services provider’s stock worth $14,925,000 after purchasing an additional 3,412 shares during the last quarter. 52.75% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This report was posted by Zolmax and is the sole property of of Zolmax. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://zolmax.com/investing/sierra-bancorp-bsrr-reaches-new-52-week-low-at-22-68/2983366.html.

About Sierra Bancorp (NASDAQ:BSRR)

Sierra Bancorp operates as the bank holding company for Bank of the Sierra that provides retail and commercial banking services to individuals and businesses in California. The company accepts various deposit products, such as checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts.

Further Reading: Discover Your Risk Tolerance

Receive News & Ratings for Sierra Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sierra Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Albireo Pharma Inc  Expected to Announce Earnings of -$1.44 Per Share
Albireo Pharma Inc Expected to Announce Earnings of -$1.44 Per Share
Dynex Capital Inc  Plans Monthly Dividend of $0.18
Dynex Capital Inc Plans Monthly Dividend of $0.18
Insider Buying: Ipsidy Inc  CFO Acquires $25,000.00 in Stock
Insider Buying: Ipsidy Inc CFO Acquires $25,000.00 in Stock
Kenneth Michael Dedeluk Sells 5,000 Shares of Computer Modelling Group Ltd.  Stock
Kenneth Michael Dedeluk Sells 5,000 Shares of Computer Modelling Group Ltd. Stock
Tabula Rasa HealthCare Inc  Director Sells $51,520.00 in Stock
Tabula Rasa HealthCare Inc Director Sells $51,520.00 in Stock
Insider Buying: Immunomedics, Inc.  Insider Purchases $66,750.00 in Stock
Insider Buying: Immunomedics, Inc. Insider Purchases $66,750.00 in Stock


 
© 2006-2019 Zolmax.